SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-23-018359
Filing Date
2023-05-05
Accepted
2023-05-05 16:35:33
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-05-05

Document Format Files

Seq Description Document Type Size
1 ARS ars_2022_annual_report_-.pdf ARS 764529
  Complete submission text file 0000950170-23-018359.txt   1054273
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39676 | Film No.: 23894463
SIC: 2836 Biological Products, (No Diagnostic Substances)